Incurred sample reanalysis comparison of dried blood spots and plasma samples on the measurement of lopinavir in clinical samples.
BACKGROUND
Undoubtedly, incurred sample reanalysis (ISR) will become an integral part of regulated bioanalysis of dried blood spot (DBS) samples. In this article, we report results from an ISR study on DBS specimen and their corresponding plasma samples. Incurred samples were reanalyzed on their concentration of the antiretroviral drug lopinavir (LPV).


RESULTS
Bland-Altman comparison plots showed a high degree of agreement between the measurements; 94.7% of observed LPV concentrations were within bias ±2 SD. Moreover, 73.7% of obtained LPV concentrations from DBS ISR were in good compliance with general acceptance criteria (4-6-20 rule) on ISR testing, while plasma ISR failed on these acceptance criteria due to the low compliance of 10.5%.


CONCLUSIONS
It was demonstrated that plasma ISR testing failed on acceptance criteria while corresponding incurred DBS specimens passed. Furthermore, the current article demonstrates that the stability of the antiretroviral drug LPV was significantly different in both biological matrices.
Department of Neurology, Laboratory of Neuro-Oncology & Clinical & Cancer Proteomics, University Medical Center Rotterdam (ErasmusMC), Dr. Molewaterplein 50, 3015 GE, Rotterdam, The Netherlands. r.meesters@erasmusmc.nl
Roland J W
RJ
Meesters
Gero P
GP
Hooff
Rob
R
Gruters
Jeroen J A
JJ
van Kampen
Theo M
TM
Luider
D019380:Anti-HIV Agents / Q000097:blood* / Q000627:therapeutic use; D059788:Dried Blood Spot Testing; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D061466:Lopinavir / Q000097:blood* / Q000627:therapeutic use; D015203:Reproducibility of Results; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
D019380:Anti-HIV Agents; D061466:Lopinavir